Maintenance therapy is an aspect of acute myeloid leukemia (AML) management that currently demonstrates strong promise in efforts to prolong survivability and improve overall survival. Given the forthcoming evidence in this area, it is highly important for health care professionals responsible for the care of patients with AML to be aware of both new treatment standards and
Multiple myeloma disproportionately affects Black Americans, who are twice as likely to be diagnosed with it and its precursor, monoclonal gammopathy of undetermined significance (MGUS).…
This video presents the 5-year off-treatment analyses from the CLL14 and MURANO studies.
Below are videos of three women entrepreneurs being interviewed by Jim Pulcrano, Professor at IMD
Sacituzumab tirumotecan monotherapy demonstrated antitumor activity with a manageable safety profile in previously treated endometrial and ovarian cancers.
In this issue of Blood Advances, Badawy et al1 address the issue of neutropenia and its associated long-term infection risks in a large cohort of patients
Binod Dhakal, MD, MS, discusses some of the next steps for evaluating ciltacabtagene autoleucel in multiple myeloma and the CARTITUDE-4 trial.
Despite aging being one of the strongest risk factors for cancer, little is known about the biological mechanisms that promote tumor initiation. In this issue…
The NCCN recently updated guidelines for genetic testing in breast, ovarian, pancreatic, prostate, colorectal, endometrial, and gastric cancers.
By continuin g to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use…
Overview for AACR Special Conference in Cancer Research: Functional and Genomic Precision Medicine in Cancer: Different Perspectives, Common Goals
